Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Trial

Telepanel

Nov 21, 2019 12:54PM

Re: Trial

Nextblockbuster

Nov 21, 2019 01:09PM

Re: Trial

Telepanel

Nov 21, 2019 01:21PM

Re: Trial

RVXoldtimer

Nov 21, 2019 01:48PM

Re: Trial

Nextblockbuster

Nov 21, 2019 01:49PM

Re: Trial

Telepanel

Nov 21, 2019 02:15PM

Re: Trial

BearDownAZ

Nov 21, 2019 02:30PM

RVXoldtimer

Rank: President [?]

Points: 3190 [?]

Votes: 23 Score: 3.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Trial

in response to

Re: Trial

Telepanel

posted on Nov 21, 2019 02:47PM

I would agree that 44 of 58 experiencing benefit speaks well for the success of the original trial.

7 Recommendations

Reply New Message

Back To Forum List View

Please to post a reply